J&J to restart Covid vac­cine ship­ments to Eu­rope as EMA adds safe­ty warn­ing over rare blood clots

The Eu­ro­pean Med­i­cines Agency’s safe­ty com­mit­tee on Tues­day rec­om­mend­ed adding a warn­ing to the J&J Covid-19 vac­cine re­gard­ing the rare but some­times fa­tal blood clots with low blood platelets. Short­ly there­after, J&J said it would re­sume ship­ments of the vac­cine to the EU, Nor­way and Ice­land, and up­date its vac­cine’s Sum­ma­ry of Prod­uct Char­ac­ter­is­tics and Pack­age Leaflet to in­clude in­for­ma­tion on the di­ag­no­sis and man­age­ment of these very rare ad­verse events.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER